Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment
- 1 August 1997
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 20 (4) , 273-281
- https://doi.org/10.1038/sj.bmt.1700882
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 0 references indexed in Scilit: